Left ventricular (LV) pseudoaneurysm is a rare and grave complication of acute myocardial infarction. If left undetected, it has an extremely high rate of mortality. It is complicated by a ventricular free wall rupture contained by the pericardium and is characterized by the absence of myocardial tissue in its wall. The clinical presentation of these patients is nonspecific, making the diagnosis challenging. We came across a case of LV pseudoaneurysm diagnosed by transthoracic echocardiography, but unfortunately, the patient passed away within a few hours of presentation in the emergency department. This case depicts the importance of prompt diagnosis and management of such deadly complication.
Background: Dengue and Japanese encephalitis are considered as one of the most common arbovirus diseases in tropics. Dengue virus has a wide spectrum of presentation starting from the classical dengue fever to dengue encephalitis and dengue shock syndrome. Moreover, Japanese encephalitis, which is one of the major public health problems in most of the South East Asian countries including India, may present with similar clinical picture mimicking dengue encephalitis. Case Report: We report the case of a 34 year old male patient who presented to the emergency department with complaints of fever and subsequently developed altered mental status. Investigations of the patient revealed dengue NS1 antigen positive but Magnetic Resonance Imaging findings were suggestive of Japanese encephalitis. Conclusion: Here, we discuss the likelihood of DengueJapanese encephalitis co-infection in endemic countries where both dengue and Japanese encephalitis are common.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.